Llwytho...
A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
BACKGROUND: Pathologic vascular smooth muscle cell (VSMC) proliferation and migration after vascular injury promotes the development of occlusive vascular disease. Therefore, an effective chemical agent to suppress aberrant proliferation and migration of VSMCs can be a potential therapeutic modality...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Biol Res |
|---|---|
| Prif Awduron: | , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5244549/ https://ncbi.nlm.nih.gov/pubmed/28100269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40659-016-0106-3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|